Atlas Trials

To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin

Clinical trial NCT01363934 · COMPLETED

Trial details

NCT number
NCT01363934
Sponsor
Green Cross Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2011-06-01
Primary completion
2012-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.